Vivos Inc. (OTCMKTS:RDGL) Short Interest Down 67.8% in February

Vivos Inc. (OTCMKTS:RDGL) was the recipient of a significant drop in short interest during the month of February. As of February 15th, there was short interest totalling 5,800 shares, a drop of 67.8% from the January 31st total of 18,000 shares. Based on an average daily trading volume, of 2,339,200 shares, the short-interest ratio is presently 0.0 days.

Vivos Trading Down 2.4 %

Shares of OTCMKTS RDGL traded down $0.00 during mid-day trading on Friday, reaching $0.11. 1,219,055 shares of the company’s stock were exchanged, compared to its average volume of 1,358,471. The firm has a market capitalization of $49.00 million, a price-to-earnings ratio of -10.80 and a beta of 0.89. The business has a fifty day simple moving average of $0.13 and a 200 day simple moving average of $0.13. Vivos has a twelve month low of $0.05 and a twelve month high of $0.26.

About Vivos

Vivos Inc, a radiation oncology medical device company, develops brachytherapy devices for the treatment of non-resectable tumors in the United States. It develops yttrium-90 based RadioGel device, an injectable particle-gel for brachytherapy radiation treatment of cancerous tumors in people and animals; and IsoPet for the treatment of solid tumors in animals.